Evidence map›Paper›PMID 29916117›Full record

ArticleMolecular imaging and biology2019

Mapping Bone Marrow Response in the Vertebral Column by Positron Emission Tomography Following Radiotherapy and Erlotinib Therapy of Lung Cancer.

Azadeh Abravan, Hanne Astrid Eide, Ayca Muftuler Løndalen, Åslaug Helland, Eirik Malinen

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02714530 (Concomitant Radiotherapy and Erlotinib in Advanced Lung Cancer), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02714530 phase2terminatednot on this map

Concomitant Radiotherapy and Erlotinib in Advanced Lung Cancer

TypeinterventionalSponsorOslo University HospitalRan2014 to 2020Enrolled118ConditionsCancerArmsErlotinib, Radiation
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Azadeh AbravanDepartment of Medical Physics, Oslo University Hospital, PO Box 4953, Nydalen, N-0424, Oslo, Norway. azadeh.abravan@fys.uio.no.ORCID http://orcid.org/0000-0003-4839-6705
Hanne Astrid EideDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Ayca Muftuler LøndalenDepartment of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Åslaug HellandDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Eirik MalinenDepartment of Medical Physics, Oslo University Hospital, PO Box 4953, Nydalen, N-0424, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo map functional bone marrow (BM) by 2-deoxy-2-[ PROCEDURES: Twenty-six patients with advanced non-small cell lung cancer, receiving radiotherapy (RT) alone or concomitantly with erlotinib, were examined by [

resultsA homogeneous uptake of [

conclusionsRT reduces BM [

trial registrationNCT02714530. Registered 10 September 2015.

Indexed as

Positron-Emission TomographyAgedAged, 80 and overBone MarrowDose-Response Relationship, RadiationErlotinib HydrochlorideFemaleFluorodeoxyglucose F18HumansLiverLung NeoplasmsMaleMiddle AgedSpineTomography, X-Ray ComputedErlotinib HydrochlorideFluorodeoxyglucose F18Bone marrowErlotinibFDG-PETNSCLCThoracic radiotherapyVertebral column

Identifiers

PMID29916117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.